47 results on '"Sebag-Montefiore D"'
Search Results
2. OC-0831 Standard vs dose reduced chemoradiotherapy in anal cancer: short-term results of the PLATO-ACT4 RCT
3. OC-0909 COVID RT – a national study of radiotherapy decisions and their impact on patient outcomes.
4. OC-0272 Organ preservation in rectal cancer: the randomised STAR-TREC phase II trial
5. OC-0269 Standard vs dose escalated chemoradiotherapy in anal cancer: Phase II results of the PLATO-ACT5 RCT
6. PO-1321 Prognostic factors for anal cancer treated with conformal radiotherapy – a systematic review
7. OC-0103 SCALOP2:A multicenter randomized trial of RT dose escalation and nelfinavir in pancreatic cancer
8. OC-0524 Evidence supporting anal and rectal cancer MR-only radiotherapy planning clinical implementation
9. OC-0420 Assessing plan quality in the ‘PLATO anal cancer trial 5’ pilot phase with automated planning
10. PO-1638: Treatment delivery uncertainties in rectal cancer radiotherapy – evidence-based margin estimates
11. SP-0490: The treatment of anal cancer
12. PH-0410: Multi-centre, deep learning, sCT generation for anorectal cancers with AI robustness assessment
13. PO-1303: Radiotherapy platform trials: accelerating our ability to answer important scientific questions
14. PH-0161: Elective clinical target volumes for rectal IMRT delivery – moving towards a UK wide consensus
15. PH-0649: Can we dose escalate in anal cancer without an increase in dose to OARs?
16. PH-0162: Is there a radiation dose-response relationship for non-operative management of rectal cancer?
17. International expert consensus statement regarding radiotherapy treatment options for rectal cancer during the COVID 19 pandemic
18. PO-0786: Outcomes from hypofractionated radiotherapy comparable to chemoradiotherapy in oesophageal cancer
19. PO-0905: Data mining for pre-plan evaluation of organ at risk priority
20. SP-0345: For the motion seconder
21. EP-2136: Assessing the stability of MRI geometric distortions on multiple scanners
22. EP-1696: Evaluating excellence in radiotherapy research: the UK CTRad ‘Centres of Excellence’ initiative
23. EP-1732: Treatment planning of dose escalation for anal cancer in the PLATO trial
24. SP-0519: Collecting PROs in clinical practice to assess radiotherapy toxicity and develop normal tissue complication probability models
25. OC-0255: Practical use of principal component analysis in radiotherapy planning
26. EP-1277: Optimising RT dose for anal cancer - the development of three clinical trials in one platform
27. PO-0853: A method for automatic selection of parameters in NTCP modelling
28. EP-1748: Mesorectal-only irradiation for early stage rectal cancer: Target volumes and dose to organs at risk
29. EP-1708: Investigating the reproducibility of geometric distortion measurements for MR-only radiotherapy
30. EP-1918: Radiotherapy quality assurance in the TREC trial
31. PO-0713: Conformity analysis of target-volume definition for margin-directed boost in pancreatic cancer SBRT
32. SP-0182: Anal cancer: current guidelines and remaining questions
33. EP-1211: A systematic review of novel neoadjuvant treatment intensification of locally advanced rectal cancer
34. EP-1322: 3D-CRT, VMAT and dose escalation for pancreatic radiotherapy planning
35. EP-1706:A pilot study examining deformable imaging in deriving a PET-based PTV for oesophageal cancer radiotherapy planning
36. OC-0077: Risk of second malignancy following prostate radiotherapy using modern radiotherapy techniques
37. EP-1307: Pre-trial quality assurance of radiotherapy for the NCRI Aristotle Trial
38. SP-0386: Against the motion
39. PO-0695: Value of deformable image registration in assessing local relapse site after chemoradiation in oesophageal cancer
40. EP-1533 STEREOTACTIC BODY RADIATION THERAPY DELIVERED USING VOLUMETRIC MODULATED ARC THERAPY IN EARLY PROSTATE CANCER
41. PO-0792 THE DEVELOPMENT OF A CONFORMAL RADIOTHERAPY PROTOCOL FOR THE PHASE III ARISTOTLE RECTAL CANCER TRIAL
42. OC-0219 THE MRC CR07 TRIAL NCIC CO16 TRIAL AFTER A MEDIAN FOLLOW UP OF 8 YEARS
43. PO-0965 QUALITY ASSURANCE OF TARGET VOLUME DEFINITION IN THE ARISTOTLE PHASE III RECTAL CANCER TRIAL – INITIAL ASSESSMENT
44. SP-0364 NEOADJUVANT RT: LOWER GI (RECTUM AND ANUS)
45. 679 poster SINGLE CENTRE EXPERIENCE USING 3D CT CONFORMAL PLANNING FOR PATIENTS TREATED WITH INTRALUMINAL BRACHYTHERAPY (ILBT) IN OESOPHAGEAL CANCER
46. 46 speaker EVIDENCE FROM META-ANALYSES (SHORT COURSE, RADIOCHEMOTHERAPY, ADJUVANT CHEMOTHERAPY)
47. 936 poster DOSE ESCALATION STUDY USING 4D CT PLANNING IN LOCALLY ADVANCED PANCREATIC CANCER
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.